

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 7.59368764 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.10943141 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.10943141 |
| 4 | nuclear pore organization (GO:0006999) | 6.81526157 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 6.59446311 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.59446311 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.48298754 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.92839407 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.92839407 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.92839407 |
| 11 | cysteine metabolic process (GO:0006534) | 5.73435926 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.65141497 |
| 13 | pore complex assembly (GO:0046931) | 5.59065054 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.55722784 |
| 15 | kynurenine metabolic process (GO:0070189) | 5.55139814 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.49119079 |
| 17 | bile acid biosynthetic process (GO:0006699) | 5.48646248 |
| 18 | mitotic sister chromatid cohesion (GO:0007064) | 5.25312455 |
| 19 | urea cycle (GO:0000050) | 5.11743957 |
| 20 | urea metabolic process (GO:0019627) | 5.11743957 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 5.09491310 |
| 22 | homocysteine metabolic process (GO:0050667) | 5.05361576 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 5.02240538 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 4.86789782 |
| 25 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.84299442 |
| 26 | mitotic chromosome condensation (GO:0007076) | 4.81052473 |
| 27 | lysine catabolic process (GO:0006554) | 4.75178653 |
| 28 | lysine metabolic process (GO:0006553) | 4.75178653 |
| 29 | high-density lipoprotein particle remodeling (GO:0034375) | 4.72898220 |
| 30 | bile acid metabolic process (GO:0008206) | 4.71996898 |
| 31 | regulation of protein activation cascade (GO:2000257) | 4.70210433 |
| 32 | complement activation, alternative pathway (GO:0006957) | 4.68913212 |
| 33 | regulation of fibrinolysis (GO:0051917) | 4.68328694 |
| 34 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.68119469 |
| 35 | protein carboxylation (GO:0018214) | 4.68119469 |
| 36 | nitrogen cycle metabolic process (GO:0071941) | 4.67299430 |
| 37 | serine family amino acid catabolic process (GO:0009071) | 4.66547901 |
| 38 | aromatic amino acid family metabolic process (GO:0009072) | 4.60888452 |
| 39 | tyrosine metabolic process (GO:0006570) | 4.49907394 |
| 40 | cellular glucuronidation (GO:0052695) | 4.46686600 |
| 41 | bile acid and bile salt transport (GO:0015721) | 4.42177229 |
| 42 | acylglycerol homeostasis (GO:0055090) | 4.40164405 |
| 43 | triglyceride homeostasis (GO:0070328) | 4.40164405 |
| 44 | regulation of complement activation (GO:0030449) | 4.38778225 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 4.38271160 |
| 46 | drug transmembrane transport (GO:0006855) | 4.29286746 |
| 47 | alpha-amino acid catabolic process (GO:1901606) | 4.28572712 |
| 48 | indolalkylamine metabolic process (GO:0006586) | 4.23104304 |
| 49 | reverse cholesterol transport (GO:0043691) | 4.21594614 |
| 50 | amino-acid betaine metabolic process (GO:0006577) | 4.21559312 |
| 51 | cellular biogenic amine catabolic process (GO:0042402) | 4.13378291 |
| 52 | amine catabolic process (GO:0009310) | 4.13378291 |
| 53 | glutamate metabolic process (GO:0006536) | 4.07849218 |
| 54 | negative regulation of cholesterol transport (GO:0032375) | 4.07386702 |
| 55 | negative regulation of sterol transport (GO:0032372) | 4.07386702 |
| 56 | serine family amino acid metabolic process (GO:0009069) | 4.07348729 |
| 57 | plasma lipoprotein particle remodeling (GO:0034369) | 4.05996755 |
| 58 | protein-lipid complex remodeling (GO:0034368) | 4.05996755 |
| 59 | macromolecular complex remodeling (GO:0034367) | 4.05996755 |
| 60 | glucuronate metabolic process (GO:0019585) | 4.05759995 |
| 61 | uronic acid metabolic process (GO:0006063) | 4.05759995 |
| 62 | coenzyme catabolic process (GO:0009109) | 4.03563349 |
| 63 | drug catabolic process (GO:0042737) | 4.02790222 |
| 64 | plasma lipoprotein particle clearance (GO:0034381) | 3.99808534 |
| 65 | benzene-containing compound metabolic process (GO:0042537) | 3.99079416 |
| 66 | phospholipid efflux (GO:0033700) | 3.98211794 |
| 67 | imidazole-containing compound metabolic process (GO:0052803) | 3.97359188 |
| 68 | cellular amino acid catabolic process (GO:0009063) | 3.94879907 |
| 69 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.91264073 |
| 70 | cellular modified amino acid catabolic process (GO:0042219) | 3.88642597 |
| 71 | serine family amino acid biosynthetic process (GO:0009070) | 3.86891776 |
| 72 | urate metabolic process (GO:0046415) | 3.86500977 |
| 73 | regulation of cholesterol esterification (GO:0010872) | 3.85369287 |
| 74 | response to nitrosative stress (GO:0051409) | 3.85201359 |
| 75 | cholesterol efflux (GO:0033344) | 3.84764302 |
| 76 | cellular ketone body metabolic process (GO:0046950) | 3.84470809 |
| 77 | glycine metabolic process (GO:0006544) | 3.84063034 |
| 78 | regulation of bile acid biosynthetic process (GO:0070857) | 3.80957224 |
| 79 | ethanol oxidation (GO:0006069) | 3.79117663 |
| 80 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.78339729 |
| 81 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.78339729 |
| 82 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.75195477 |
| 83 | ribosome assembly (GO:0042255) | 3.74252931 |
| 84 | plasma lipoprotein particle assembly (GO:0034377) | 3.70715342 |
| 85 | DNA unwinding involved in DNA replication (GO:0006268) | 3.66809392 |
| 86 | cholesterol homeostasis (GO:0042632) | 3.62896741 |
| 87 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.62291104 |
| 88 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.62291104 |
| 89 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.62291104 |
| 90 | sterol homeostasis (GO:0055092) | 3.61043143 |
| 91 | short-chain fatty acid metabolic process (GO:0046459) | 3.60405402 |
| 92 | phospholipid homeostasis (GO:0055091) | 3.59357884 |
| 93 | fibrinolysis (GO:0042730) | 3.59169541 |
| 94 | intestinal cholesterol absorption (GO:0030299) | 3.58659608 |
| 95 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.57432368 |
| 96 | regulation of cholesterol homeostasis (GO:2000188) | 3.56816182 |
| 97 | exogenous drug catabolic process (GO:0042738) | 3.51859086 |
| 98 | mitotic metaphase plate congression (GO:0007080) | 3.51227921 |
| 99 | protein localization to chromosome, centromeric region (GO:0071459) | 3.50161166 |
| 100 | aldehyde catabolic process (GO:0046185) | 3.49619957 |
| 101 | NAD biosynthetic process (GO:0009435) | 3.48677516 |
| 102 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.47733213 |
| 103 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.47733213 |
| 104 | acetyl-CoA metabolic process (GO:0006084) | 3.46904809 |
| 105 | drug transport (GO:0015893) | 3.45327360 |
| 106 | carboxylic acid catabolic process (GO:0046395) | 3.45083224 |
| 107 | organic acid catabolic process (GO:0016054) | 3.45083224 |
| 108 | cofactor catabolic process (GO:0051187) | 3.43972601 |
| 109 | positive regulation of lipid catabolic process (GO:0050996) | 3.42573680 |
| 110 | lipoprotein metabolic process (GO:0042157) | 3.42323873 |
| 111 | blood coagulation, intrinsic pathway (GO:0007597) | 3.40631623 |
| 112 | protein-lipid complex assembly (GO:0065005) | 3.37134818 |
| 113 | aspartate family amino acid catabolic process (GO:0009068) | 3.35892609 |
| 114 | mitotic nuclear envelope disassembly (GO:0007077) | 3.35800922 |
| 115 | nuclear envelope disassembly (GO:0051081) | 3.34928341 |
| 116 | membrane disassembly (GO:0030397) | 3.34928341 |
| 117 | regulation of RNA export from nucleus (GO:0046831) | 3.33426715 |
| 118 | dosage compensation (GO:0007549) | 3.23033474 |
| 119 | DNA duplex unwinding (GO:0032508) | 3.12708489 |
| 120 | positive regulation of chromosome segregation (GO:0051984) | 3.10290701 |
| 121 | sister chromatid segregation (GO:0000819) | 3.09745393 |
| 122 | establishment of chromosome localization (GO:0051303) | 3.05317992 |
| 123 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.02499494 |
| 124 | metaphase plate congression (GO:0051310) | 3.01568729 |
| 125 | DNA geometric change (GO:0032392) | 3.01049225 |
| 126 | COPII vesicle coating (GO:0048208) | 3.01039405 |
| 127 | cellular protein complex localization (GO:0034629) | 2.98968133 |
| 128 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.98723124 |
| 129 | ER overload response (GO:0006983) | 2.96083594 |
| 130 | cellular response to ethanol (GO:0071361) | 2.95861634 |
| 131 | iron ion import (GO:0097286) | 2.90647548 |
| 132 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.89740253 |
| 133 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.88806177 |
| 134 | mitotic sister chromatid segregation (GO:0000070) | 2.85858825 |
| 135 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.85081571 |
| 136 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.79429578 |
| 137 | regulation of translational fidelity (GO:0006450) | 2.77916534 |
| 138 | regulation of sister chromatid cohesion (GO:0007063) | 2.77218853 |
| 139 | hepatocyte apoptotic process (GO:0097284) | 2.75978188 |
| 140 | embryonic process involved in female pregnancy (GO:0060136) | 2.73840181 |
| 141 | protein export from nucleus (GO:0006611) | 2.72879276 |
| 142 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.72572182 |
| 143 | nuclear envelope organization (GO:0006998) | 2.71868136 |
| 144 | hypotonic response (GO:0006971) | 2.71783282 |
| 145 | response to peptidoglycan (GO:0032494) | 2.66086653 |
| 146 | chromosome condensation (GO:0030261) | 2.65255639 |
| 147 | histone phosphorylation (GO:0016572) | 2.64213306 |
| 148 | negative regulation of DNA repair (GO:0045738) | 2.63329962 |
| 149 | necroptotic process (GO:0070266) | 2.62495768 |
| 150 | regulation of DNA endoreduplication (GO:0032875) | 2.61732298 |
| 151 | non-recombinational repair (GO:0000726) | 2.59866398 |
| 152 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.59866398 |
| 153 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.59168232 |
| 154 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.59168232 |
| 155 | negative regulation of interleukin-12 production (GO:0032695) | 2.58628829 |
| 156 | RNA stabilization (GO:0043489) | 2.57569749 |
| 157 | mRNA stabilization (GO:0048255) | 2.57569749 |
| 158 | DNA conformation change (GO:0071103) | 2.57429828 |
| 159 | mRNA modification (GO:0016556) | 2.56699969 |
| 160 | regulation of centriole replication (GO:0046599) | 2.55123890 |
| 161 | protein localization to kinetochore (GO:0034501) | 2.54991356 |
| 162 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.54117676 |
| 163 | regulation of chromosome segregation (GO:0051983) | 2.53662610 |
| 164 | sister chromatid cohesion (GO:0007062) | 2.52139149 |
| 165 | oligosaccharide catabolic process (GO:0009313) | 2.51511474 |
| 166 | regulation of translational termination (GO:0006449) | 2.49440247 |
| 167 | cytoskeleton-dependent cytokinesis (GO:0061640) | 2.49198165 |
| 168 | protein localization to endosome (GO:0036010) | 2.48894123 |
| 169 | detection of molecule of bacterial origin (GO:0032490) | 2.46931224 |
| 170 | pre-miRNA processing (GO:0031054) | 2.45460120 |
| 171 | Golgi transport vesicle coating (GO:0048200) | 2.42276445 |
| 172 | COPI coating of Golgi vesicle (GO:0048205) | 2.42276445 |
| 173 | neutrophil activation involved in immune response (GO:0002283) | 2.42030372 |
| 174 | regulation of sister chromatid segregation (GO:0033045) | 2.41634792 |
| 175 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.41634792 |
| 176 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.41634792 |
| 177 | protein complex localization (GO:0031503) | 2.38074116 |
| 178 | regulation of histone H3-K27 methylation (GO:0061085) | 2.35723666 |
| 179 | DNA packaging (GO:0006323) | 2.35586489 |
| 180 | histone mRNA catabolic process (GO:0071044) | 2.35307347 |
| 181 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.34081786 |
| 182 | protein localization to chromosome (GO:0034502) | 2.33864470 |
| 183 | DNA synthesis involved in DNA repair (GO:0000731) | 2.33257601 |
| 184 | mitotic cytokinesis (GO:0000281) | 2.30612438 |
| 185 | peptidyl-threonine dephosphorylation (GO:0035970) | 2.30138344 |
| 186 | negative regulation of chromosome segregation (GO:0051985) | 2.29820830 |
| 187 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.29513481 |
| 188 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.28990677 |
| 189 | meiotic chromosome segregation (GO:0045132) | 2.28699109 |
| 190 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.28586899 |
| 191 | cellular response to arsenic-containing substance (GO:0071243) | 2.27040608 |
| 192 | spindle checkpoint (GO:0031577) | 2.23526828 |
| 193 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.23119614 |
| 194 | negative regulation of sister chromatid segregation (GO:0033046) | 2.23119614 |
| 195 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.23119614 |
| 196 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.23119614 |
| 197 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.23119614 |
| 198 | histone-serine phosphorylation (GO:0035404) | 2.22543666 |
| 199 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.22403457 |
| 200 | mitotic spindle checkpoint (GO:0071174) | 2.22099418 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.93247612 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.23484397 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.44605377 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.16186284 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.91465516 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.33571584 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.25533997 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.20023332 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.94762916 |
| 10 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.66408588 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.45082173 |
| 12 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.24384151 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.03941323 |
| 14 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.74891889 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.65614579 |
| 16 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.53948599 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.46971843 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.41936894 |
| 19 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.25991663 |
| 20 | TFEB_21752829_ChIP-Seq_HELA_Human | 2.11165478 |
| 21 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.10312088 |
| 22 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.06464206 |
| 23 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.01363359 |
| 24 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.0637523 |
| 25 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.93493655 |
| 26 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.93183059 |
| 27 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.92316207 |
| 28 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.86573191 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.84836233 |
| 30 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.84165775 |
| 31 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.83326316 |
| 32 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.81283432 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.80369321 |
| 34 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.72845912 |
| 35 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.70979849 |
| 36 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.69786449 |
| 37 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60748840 |
| 38 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.59829127 |
| 39 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.59026668 |
| 40 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.58796131 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.55010113 |
| 42 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.53875264 |
| 43 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.50847481 |
| 44 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.49881786 |
| 45 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.49881786 |
| 46 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.48216792 |
| 47 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.47619252 |
| 48 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.46899420 |
| 49 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.43287380 |
| 50 | MYC_22102868_ChIP-Seq_BL_Human | 1.42246153 |
| 51 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41433266 |
| 52 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.41155094 |
| 53 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.40628384 |
| 54 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.40595200 |
| 55 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.40488937 |
| 56 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.40096979 |
| 57 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.38918997 |
| 58 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.36575049 |
| 59 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.35364516 |
| 60 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.34693482 |
| 61 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.33909595 |
| 62 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33586230 |
| 63 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.29595729 |
| 64 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.29060536 |
| 65 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.25804854 |
| 66 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 1.24673711 |
| 67 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.24637363 |
| 68 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.24637363 |
| 69 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.23999433 |
| 70 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.23642573 |
| 71 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.22909156 |
| 72 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21836110 |
| 73 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20742362 |
| 74 | MYB_26560356_Chip-Seq_TH1_Human | 1.19507889 |
| 75 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.19312429 |
| 76 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.17507823 |
| 77 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.16828345 |
| 78 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.15647030 |
| 79 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.11922578 |
| 80 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11547007 |
| 81 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.11105619 |
| 82 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.11098306 |
| 83 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.10533267 |
| 84 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10440398 |
| 85 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.09523678 |
| 86 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.09323727 |
| 87 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.09224193 |
| 88 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07391604 |
| 89 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.06319830 |
| 90 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.06140578 |
| 91 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.05927016 |
| 92 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.05821194 |
| 93 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05612569 |
| 94 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.05155662 |
| 95 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04037332 |
| 96 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.02355467 |
| 97 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01566853 |
| 98 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.01193089 |
| 99 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.00779443 |
| 100 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00265805 |
| 101 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98959159 |
| 102 | MYB_26560356_Chip-Seq_TH2_Human | 0.98496556 |
| 103 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.96074937 |
| 104 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.94478784 |
| 105 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.93960807 |
| 106 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.92034370 |
| 107 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.91877193 |
| 108 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.91659740 |
| 109 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.91642653 |
| 110 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.91270198 |
| 111 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.91161585 |
| 112 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.90832656 |
| 113 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.88279089 |
| 114 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.87836020 |
| 115 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.87101853 |
| 116 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.86298707 |
| 117 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.86237571 |
| 118 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.85925438 |
| 119 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.85615457 |
| 120 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.84961013 |
| 121 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83143590 |
| 122 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.83035537 |
| 123 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.82478970 |
| 124 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.81818855 |
| 125 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.81519471 |
| 126 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.81043665 |
| 127 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.80301721 |
| 128 | ATF3_27146783_Chip-Seq_COLON_Human | 0.79985261 |
| 129 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.79443757 |
| 130 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.79338895 |
| 131 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.78313077 |
| 132 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.76865552 |
| 133 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.76613491 |
| 134 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.74306445 |
| 135 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.72861477 |
| 136 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.72729731 |
| 137 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.72656513 |
| 138 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.72515690 |
| 139 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.71748256 |
| 140 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.70170202 |
| 141 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.69720365 |
| 142 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.69585683 |
| 143 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.67568115 |
| 144 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.67514082 |
| 145 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.67139609 |
| 146 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.66241646 |
| 147 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.65658302 |
| 148 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.64348382 |
| 149 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.64217884 |
| 150 | GATA2_19941826_ChIP-Seq_K562_Human | 0.63837490 |
| 151 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.63538891 |
| 152 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.62154422 |
| 153 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.61808902 |
| 154 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.61454119 |
| 155 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.61302875 |
| 156 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.60844098 |
| 157 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.60842454 |
| 158 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.60154205 |
| 159 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60123023 |
| 160 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.59948404 |
| 161 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.59943894 |
| 162 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.58972290 |
| 163 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.58563346 |
| 164 | GATA1_19941826_ChIP-Seq_K562_Human | 0.57926134 |
| 165 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.57124011 |
| 166 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.57039460 |
| 167 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.56659356 |
| 168 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.56297277 |
| 169 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.55815608 |
| 170 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.55635898 |
| 171 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.55503416 |
| 172 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.55357747 |
| 173 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.54754909 |
| 174 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.54665784 |
| 175 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.54649167 |
| 176 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.54250946 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.74200356 |
| 2 | MP0005360_urolithiasis | 7.41305285 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.93466025 |
| 4 | MP0005365_abnormal_bile_salt | 5.60787011 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.77821702 |
| 6 | MP0008057_abnormal_DNA_replication | 4.43603084 |
| 7 | * MP0003252_abnormal_bile_duct | 4.24017145 |
| 8 | MP0010352_gastrointestinal_tract_polyps | 4.05227849 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.88218132 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.21518527 |
| 11 | MP0003195_calcinosis | 3.20292281 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.87551155 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.84950418 |
| 14 | MP0005332_abnormal_amino_acid | 2.74459142 |
| 15 | MP0003111_abnormal_nucleus_morphology | 2.61623119 |
| 16 | MP0010094_abnormal_chromosome_stability | 2.58980245 |
| 17 | MP0005083_abnormal_biliary_tract | 2.53442599 |
| 18 | MP0002009_preneoplasia | 2.40246497 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.39349701 |
| 20 | * MP0010234_abnormal_vibrissa_follicle | 2.32216742 |
| 21 | MP0009840_abnormal_foam_cell | 2.26392424 |
| 22 | MP0004957_abnormal_blastocyst_morpholog | 2.25299944 |
| 23 | MP0000569_abnormal_digit_pigmentation | 2.16208055 |
| 24 | MP0003868_abnormal_feces_composition | 2.11086014 |
| 25 | MP0005076_abnormal_cell_differentiation | 2.07081172 |
| 26 | * MP0000609_abnormal_liver_physiology | 2.05890126 |
| 27 | MP0003077_abnormal_cell_cycle | 2.01774801 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 2.01027580 |
| 29 | * MP0002118_abnormal_lipid_homeostasis | 1.96481052 |
| 30 | MP0003693_abnormal_embryo_hatching | 1.93739685 |
| 31 | MP0010307_abnormal_tumor_latency | 1.93307605 |
| 32 | MP0003303_peritoneal_inflammation | 1.87081340 |
| 33 | MP0002396_abnormal_hematopoietic_system | 1.83844848 |
| 34 | MP0008007_abnormal_cellular_replicative | 1.80977620 |
| 35 | MP0003221_abnormal_cardiomyocyte_apopto | 1.75495876 |
| 36 | * MP0005319_abnormal_enzyme/_coenzyme | 1.64906081 |
| 37 | MP0004808_abnormal_hematopoietic_stem | 1.60360318 |
| 38 | MP0004233_abnormal_muscle_weight | 1.55995959 |
| 39 | * MP0009643_abnormal_urine_homeostasis | 1.54266520 |
| 40 | MP0001730_embryonic_growth_arrest | 1.52811293 |
| 41 | MP0005451_abnormal_body_composition | 1.51725639 |
| 42 | MP0001764_abnormal_homeostasis | 1.51431925 |
| 43 | MP0003950_abnormal_plasma_membrane | 1.48327925 |
| 44 | MP0008058_abnormal_DNA_repair | 1.45430810 |
| 45 | MP0003828_pulmonary_edema | 1.44290736 |
| 46 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.43772945 |
| 47 | MP0009697_abnormal_copulation | 1.39695436 |
| 48 | MP0008260_abnormal_autophagy | 1.39077470 |
| 49 | MP0000350_abnormal_cell_proliferation | 1.32087176 |
| 50 | MP0002006_tumorigenesis | 1.30175365 |
| 51 | MP0003186_abnormal_redox_activity | 1.24678479 |
| 52 | MP0009764_decreased_sensitivity_to | 1.24171859 |
| 53 | MP0003763_abnormal_thymus_physiology | 1.21762085 |
| 54 | MP0003448_altered_tumor_morphology | 1.21343238 |
| 55 | MP0001915_intracranial_hemorrhage | 1.20923237 |
| 56 | * MP0000598_abnormal_liver_morphology | 1.19595774 |
| 57 | MP0005408_hypopigmentation | 1.18426549 |
| 58 | MP0003566_abnormal_cell_adhesion | 1.17547802 |
| 59 | * MP0002086_abnormal_extraembryonic_tissu | 1.14828238 |
| 60 | MP0000490_abnormal_crypts_of | 1.11652643 |
| 61 | MP0009763_increased_sensitivity_to | 1.10710890 |
| 62 | MP0005647_abnormal_sex_gland | 1.10619704 |
| 63 | MP0003656_abnormal_erythrocyte_physiolo | 1.08815881 |
| 64 | MP0005636_abnormal_mineral_homeostasis | 1.07692894 |
| 65 | MP0000858_altered_metastatic_potential | 1.07114042 |
| 66 | * MP0003091_abnormal_cell_migration | 1.06950810 |
| 67 | MP0001697_abnormal_embryo_size | 1.05378671 |
| 68 | * MP0008469_abnormal_protein_level | 1.04434310 |
| 69 | MP0005380_embryogenesis_phenotype | 1.04377862 |
| 70 | MP0001672_abnormal_embryogenesis/_devel | 1.04377862 |
| 71 | * MP0003453_abnormal_keratinocyte_physiol | 1.04211726 |
| 72 | * MP0001216_abnormal_epidermal_layer | 1.03219734 |
| 73 | MP0005310_abnormal_salivary_gland | 1.02838465 |
| 74 | * MP0005621_abnormal_cell_physiology | 1.02374008 |
| 75 | MP0003984_embryonic_growth_retardation | 1.01840358 |
| 76 | MP0002876_abnormal_thyroid_physiology | 1.00707393 |
| 77 | * MP0010678_abnormal_skin_adnexa | 1.00217813 |
| 78 | MP0000015_abnormal_ear_pigmentation | 1.00203436 |
| 79 | MP0003300_gastrointestinal_ulcer | 1.00143075 |
| 80 | MP0003690_abnormal_glial_cell | 0.99907148 |
| 81 | MP0005409_darkened_coat_color | 0.99343684 |
| 82 | MP0000371_diluted_coat_color | 0.99161399 |
| 83 | MP0002088_abnormal_embryonic_growth/wei | 0.98821001 |
| 84 | * MP0002080_prenatal_lethality | 0.96998209 |
| 85 | MP0005220_abnormal_exocrine_pancreas | 0.94057472 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.92960106 |
| 87 | MP0000313_abnormal_cell_death | 0.92410798 |
| 88 | MP0002405_respiratory_system_inflammati | 0.92151730 |
| 89 | MP0000604_amyloidosis | 0.90974324 |
| 90 | MP0000685_abnormal_immune_system | 0.90919299 |
| 91 | * MP0002398_abnormal_bone_marrow | 0.90355700 |
| 92 | MP0003705_abnormal_hypodermis_morpholog | 0.90110828 |
| 93 | MP0006054_spinal_hemorrhage | 0.88997265 |
| 94 | MP0003172_abnormal_lysosome_physiology | 0.88748748 |
| 95 | * MP0009642_abnormal_blood_homeostasis | 0.87440359 |
| 96 | MP0001727_abnormal_embryo_implantation | 0.85726001 |
| 97 | * MP0002019_abnormal_tumor_incidence | 0.85269821 |
| 98 | MP0005174_abnormal_tail_pigmentation | 0.84225192 |
| 99 | MP0002254_reproductive_system_inflammat | 0.83125544 |
| 100 | MP0005375_adipose_tissue_phenotype | 0.83096830 |
| 101 | MP0003786_premature_aging | 0.82726819 |
| 102 | MP0000703_abnormal_thymus_morphology | 0.82431824 |
| 103 | * MP0002136_abnormal_kidney_physiology | 0.81966802 |
| 104 | * MP0005384_cellular_phenotype | 0.81593273 |
| 105 | * MP0002928_abnormal_bile_duct | 0.81433545 |
| 106 | MP0004043_abnormal_pH_regulation | 0.81429109 |
| 107 | MP0006082_CNS_inflammation | 0.80802152 |
| 108 | MP0008932_abnormal_embryonic_tissue | 0.80640545 |
| 109 | * MP0005000_abnormal_immune_tolerance | 0.80241852 |
| 110 | * MP0002060_abnormal_skin_morphology | 0.79177208 |
| 111 | MP0000465_gastrointestinal_hemorrhage | 0.76630017 |
| 112 | MP0003724_increased_susceptibility_to | 0.76035101 |
| 113 | * MP0002452_abnormal_antigen_presenting | 0.75696013 |
| 114 | MP0002078_abnormal_glucose_homeostasis | 0.75496244 |
| 115 | MP0002722_abnormal_immune_system | 0.75252391 |
| 116 | * MP0001191_abnormal_skin_condition | 0.74186272 |
| 117 | MP0005670_abnormal_white_adipose | 0.73519020 |
| 118 | MP0001756_abnormal_urination | 0.73089705 |
| 119 | MP0003011_delayed_dark_adaptation | 0.72504224 |
| 120 | MP0005464_abnormal_platelet_physiology | 0.72399046 |
| 121 | MP0001186_pigmentation_phenotype | 0.72279370 |
| 122 | * MP0000627_abnormal_mammary_gland | 0.72140866 |
| 123 | MP0004197_abnormal_fetal_growth/weight/ | 0.72106933 |
| 124 | MP0002971_abnormal_brown_adipose | 0.71954192 |
| 125 | MP0002970_abnormal_white_adipose | 0.70854354 |
| 126 | MP0005334_abnormal_fat_pad | 0.70368784 |
| 127 | MP0001800_abnormal_humoral_immune | 0.70031451 |
| 128 | * MP0002796_impaired_skin_barrier | 0.69700526 |
| 129 | MP0005058_abnormal_lysosome_morphology | 0.69289482 |
| 130 | MP0003436_decreased_susceptibility_to | 0.67788163 |
| 131 | MP0004264_abnormal_extraembryonic_tissu | 0.66531504 |
| 132 | MP0001661_extended_life_span | 0.62740307 |
| 133 | MP0005376_homeostasis/metabolism_phenot | 0.62486058 |
| 134 | MP0005167_abnormal_blood-brain_barrier | 0.62225663 |
| 135 | MP0005666_abnormal_adipose_tissue | 0.60492594 |
| 136 | MP0005535_abnormal_body_temperature | 0.59859531 |
| 137 | MP0009384_cardiac_valve_regurgitation | 0.58044467 |
| 138 | MP0009053_abnormal_anal_canal | 0.57732941 |
| 139 | * MP0005084_abnormal_gallbladder_morpholo | 0.57386576 |
| 140 | MP0001835_abnormal_antigen_presentation | 0.57217445 |
| 141 | MP0001765_abnormal_ion_homeostasis | 0.56913974 |
| 142 | * MP0001845_abnormal_inflammatory_respons | 0.55319824 |
| 143 | MP0004381_abnormal_hair_follicle | 0.54563384 |
| 144 | MP0004782_abnormal_surfactant_physiolog | 0.53751043 |
| 145 | MP0002132_abnormal_respiratory_system | 0.52328570 |
| 146 | MP0005387_immune_system_phenotype | 0.51922102 |
| 147 | MP0001790_abnormal_immune_system | 0.51922102 |
| 148 | MP0005166_decreased_susceptibility_to | 0.50687476 |
| 149 | MP0005395_other_phenotype | 0.48053657 |
| 150 | MP0002168_other_aberrant_phenotype | 0.46327617 |
| 151 | * MP0002419_abnormal_innate_immunity | 0.45841027 |
| 152 | MP0010368_abnormal_lymphatic_system | 0.45670625 |
| 153 | MP0004947_skin_inflammation | 0.45395359 |
| 154 | MP0005448_abnormal_energy_balance | 0.44099489 |
| 155 | MP0009785_altered_susceptibility_to | 0.44004668 |
| 156 | MP0008873_increased_physiological_sensi | 0.42989770 |
| 157 | MP0010155_abnormal_intestine_physiology | 0.42532043 |
| 158 | MP0004130_abnormal_muscle_cell | 0.41774255 |
| 159 | MP0001853_heart_inflammation | 0.40951383 |
| 160 | MP0004147_increased_porphyrin_level | 0.40668086 |
| 161 | MP0003075_altered_response_to | 0.39474899 |
| 162 | MP0006036_abnormal_mitochondrial_physio | 0.37953645 |
| 163 | MP0004185_abnormal_adipocyte_glucose | 0.37351490 |
| 164 | MP0005266_abnormal_metabolism | 0.36883440 |
| 165 | MP0005025_abnormal_response_to | 0.36802016 |
| 166 | * MP0001881_abnormal_mammary_gland | 0.36727268 |
| 167 | MP0003953_abnormal_hormone_level | 0.36479871 |
| 168 | MP0009672_abnormal_birth_weight | 0.35394920 |
| 169 | MP0002166_altered_tumor_susceptibility | 0.34391041 |
| 170 | MP0002877_abnormal_melanocyte_morpholog | 0.34028960 |
| 171 | MP0003638_abnormal_response/metabolism_ | 0.33777978 |
| 172 | MP0000249_abnormal_blood_vessel | 0.33616523 |
| 173 | MP0005248_abnormal_Harderian_gland | 0.33538536 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.20741188 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.59425596 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.47826498 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.27606328 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 5.79220511 |
| 6 | Xanthomatosis (HP:0000991) | 5.71656261 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.42937598 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.99054256 |
| 9 | Joint hemorrhage (HP:0005261) | 4.58310304 |
| 10 | Complement deficiency (HP:0004431) | 4.56381099 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.43505026 |
| 12 | Epidermoid cyst (HP:0200040) | 4.36320058 |
| 13 | Fat malabsorption (HP:0002630) | 4.32350003 |
| 14 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.31106563 |
| 15 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.25089142 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.11748072 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.06685869 |
| 18 | Hypolipoproteinemia (HP:0010981) | 4.04106067 |
| 19 | Hyperglycinemia (HP:0002154) | 3.96513270 |
| 20 | Conjugated hyperbilirubinemia (HP:0002908) | 3.93452836 |
| 21 | Hyperammonemia (HP:0001987) | 3.91139456 |
| 22 | Hyperglycinuria (HP:0003108) | 3.90937929 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.89941689 |
| 24 | Ketosis (HP:0001946) | 3.86749010 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.83161156 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.83161156 |
| 27 | Papillary thyroid carcinoma (HP:0002895) | 3.72174032 |
| 28 | Abnormality of the intrinsic pathway (HP:0010989) | 3.62150532 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.60084405 |
| 30 | Hypoalphalipoproteinemia (HP:0003233) | 3.52290887 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.50468782 |
| 32 | Subacute progressive viral hepatitis (HP:0006572) | 3.48658198 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.39475205 |
| 34 | Myocardial infarction (HP:0001658) | 3.39363399 |
| 35 | Steatorrhea (HP:0002570) | 3.35050299 |
| 36 | Abnormality of complement system (HP:0005339) | 3.32764827 |
| 37 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.19234497 |
| 38 | Progressive external ophthalmoplegia (HP:0000590) | 3.13392491 |
| 39 | Hyperbilirubinemia (HP:0002904) | 3.12530375 |
| 40 | Chromsome breakage (HP:0040012) | 3.11911553 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 3.08934771 |
| 42 | Progressive muscle weakness (HP:0003323) | 3.04653746 |
| 43 | Fatigue (HP:0012378) | 3.02817498 |
| 44 | Vascular calcification (HP:0004934) | 2.99878987 |
| 45 | Hypoglycemic seizures (HP:0002173) | 2.98076570 |
| 46 | Hepatocellular carcinoma (HP:0001402) | 2.96336182 |
| 47 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.93428529 |
| 48 | Deep philtrum (HP:0002002) | 2.90387948 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.88167765 |
| 50 | Ketoacidosis (HP:0001993) | 2.86619999 |
| 51 | Hypochromic microcytic anemia (HP:0004840) | 2.82818377 |
| 52 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.77443883 |
| 53 | Acanthocytosis (HP:0001927) | 2.76640264 |
| 54 | Abnormality of serum amino acid levels (HP:0003112) | 2.71758584 |
| 55 | Termporal pattern (HP:0011008) | 2.67882765 |
| 56 | Insidious onset (HP:0003587) | 2.67882765 |
| 57 | Delayed CNS myelination (HP:0002188) | 2.67224559 |
| 58 | Cardiovascular calcification (HP:0011915) | 2.66223668 |
| 59 | Skin nodule (HP:0200036) | 2.64407358 |
| 60 | Metabolic acidosis (HP:0001942) | 2.59156318 |
| 61 | Spontaneous abortion (HP:0005268) | 2.59009348 |
| 62 | Gingival bleeding (HP:0000225) | 2.57672757 |
| 63 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.56977634 |
| 64 | Spinal cord lesions (HP:0100561) | 2.55495791 |
| 65 | Syringomyelia (HP:0003396) | 2.55495791 |
| 66 | Mitral stenosis (HP:0001718) | 2.53842079 |
| 67 | Volvulus (HP:0002580) | 2.53762287 |
| 68 | Gout (HP:0001997) | 2.53469638 |
| 69 | Rickets (HP:0002748) | 2.51287078 |
| 70 | Disinhibition (HP:0000734) | 2.50918715 |
| 71 | Acute myeloid leukemia (HP:0004808) | 2.48754540 |
| 72 | Micronodular cirrhosis (HP:0001413) | 2.48490793 |
| 73 | Scanning speech (HP:0002168) | 2.48238011 |
| 74 | Orthostatic hypotension (HP:0001278) | 2.47313995 |
| 75 | Systemic lupus erythematosus (HP:0002725) | 2.45984685 |
| 76 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.45591278 |
| 77 | Spastic diplegia (HP:0001264) | 2.44164468 |
| 78 | Thyroid carcinoma (HP:0002890) | 2.43939073 |
| 79 | Recurrent bacterial skin infections (HP:0005406) | 2.42844467 |
| 80 | Lower limb hyperreflexia (HP:0002395) | 2.40806184 |
| 81 | Esophageal varix (HP:0002040) | 2.39985945 |
| 82 | Curly hair (HP:0002212) | 2.35359973 |
| 83 | Bladder carcinoma (HP:0002862) | 2.33970284 |
| 84 | Bladder neoplasm (HP:0009725) | 2.33970284 |
| 85 | Hydroxyprolinuria (HP:0003080) | 2.32457174 |
| 86 | Abnormality of proline metabolism (HP:0010907) | 2.32457174 |
| 87 | Hypophosphatemic rickets (HP:0004912) | 2.31629810 |
| 88 | Recurrent abscess formation (HP:0002722) | 2.31482836 |
| 89 | Septate vagina (HP:0001153) | 2.31000003 |
| 90 | Menorrhagia (HP:0000132) | 2.30624198 |
| 91 | Tetraparesis (HP:0002273) | 2.28619164 |
| 92 | Dicarboxylic aciduria (HP:0003215) | 2.27153986 |
| 93 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.27153986 |
| 94 | Pancreatitis (HP:0001733) | 2.27000819 |
| 95 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.26673156 |
| 96 | Ankyloglossia (HP:0010296) | 2.26246130 |
| 97 | Abnormal foot bone ossification (HP:0010675) | 2.24228364 |
| 98 | Eczematoid dermatitis (HP:0000976) | 2.23170908 |
| 99 | Asymmetry of the thorax (HP:0001555) | 2.20872339 |
| 100 | Glomerulonephritis (HP:0000099) | 2.19356901 |
| 101 | Irritability (HP:0000737) | 2.18387512 |
| 102 | Abnormality of chromosome stability (HP:0003220) | 2.17602673 |
| 103 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.17592513 |
| 104 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.17592513 |
| 105 | Abnormality of glycolipid metabolism (HP:0010969) | 2.17592513 |
| 106 | Enlarged kidneys (HP:0000105) | 2.17005338 |
| 107 | Generalized aminoaciduria (HP:0002909) | 2.15825123 |
| 108 | Proximal tubulopathy (HP:0000114) | 2.14962792 |
| 109 | Elevated alkaline phosphatase (HP:0003155) | 2.14420488 |
| 110 | Sensorimotor neuropathy (HP:0007141) | 2.13765452 |
| 111 | Medulloblastoma (HP:0002885) | 2.13750169 |
| 112 | Leiomyosarcoma (HP:0100243) | 2.13010435 |
| 113 | Uterine leiomyosarcoma (HP:0002891) | 2.13010435 |
| 114 | Lethargy (HP:0001254) | 2.12960179 |
| 115 | Multiple enchondromatosis (HP:0005701) | 2.12603154 |
| 116 | Malnutrition (HP:0004395) | 2.11369165 |
| 117 | Alkalosis (HP:0001948) | 2.10656950 |
| 118 | Renal cortical cysts (HP:0000803) | 2.10050894 |
| 119 | Abnormal gallbladder morphology (HP:0012437) | 2.09746686 |
| 120 | Symptomatic seizures (HP:0011145) | 2.08823449 |
| 121 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.08005215 |
| 122 | Single umbilical artery (HP:0001195) | 2.08005215 |
| 123 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.08005215 |
| 124 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 2.06533098 |
| 125 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.05152757 |
| 126 | Thrombophlebitis (HP:0004418) | 2.03097008 |
| 127 | Osteolytic defects of the hand bones (HP:0009699) | 2.02660179 |
| 128 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.02660179 |
| 129 | Increased mean platelet volume (HP:0011877) | 2.01616604 |
| 130 | Gastrointestinal carcinoma (HP:0002672) | 1.98993116 |
| 131 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.98993116 |
| 132 | Amyloidosis (HP:0011034) | 1.97497777 |
| 133 | Hemorrhage of the eye (HP:0011885) | 1.96673325 |
| 134 | Periodontitis (HP:0000704) | 1.96025745 |
| 135 | Acute hepatic failure (HP:0006554) | 1.95951153 |
| 136 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.95813570 |
| 137 | Poikilocytosis (HP:0004447) | 1.94474684 |
| 138 | Abnormality of oral frenula (HP:0000190) | 1.92725303 |
| 139 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.90977975 |
| 140 | Abnormality of iron homeostasis (HP:0011031) | 1.90853672 |
| 141 | Viral hepatitis (HP:0006562) | 1.90634713 |
| 142 | Abnormal platelet volume (HP:0011876) | 1.90532041 |
| 143 | Resting tremor (HP:0002322) | 1.90093750 |
| 144 | Prominent nose (HP:0000448) | 1.90034419 |
| 145 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.90030669 |
| 146 | Fair hair (HP:0002286) | 1.89392593 |
| 147 | Opisthotonus (HP:0002179) | 1.89365532 |
| 148 | Cholelithiasis (HP:0001081) | 1.89277036 |
| 149 | Pelvic girdle muscle weakness (HP:0003749) | 1.88661582 |
| 150 | Abnormality of vitamin metabolism (HP:0100508) | 1.88126453 |
| 151 | Confusion (HP:0001289) | 1.88037247 |
| 152 | T lymphocytopenia (HP:0005403) | 1.87561753 |
| 153 | Renal cell carcinoma (HP:0005584) | 1.87095175 |
| 154 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.85897559 |
| 155 | Abnormality of urine glucose concentration (HP:0011016) | 1.85156385 |
| 156 | Glycosuria (HP:0003076) | 1.85156385 |
| 157 | Short chin (HP:0000331) | 1.84954983 |
| 158 | Abnormal cartilage morphology (HP:0002763) | 1.84723046 |
| 159 | Autoimmune hemolytic anemia (HP:0001890) | 1.84641929 |
| 160 | Autoamputation (HP:0001218) | 1.84565929 |
| 161 | Increased purine levels (HP:0004368) | 1.84516826 |
| 162 | Coarse hair (HP:0002208) | 1.84316568 |
| 163 | Selective tooth agenesis (HP:0001592) | 1.82400162 |
| 164 | Rhabdomyosarcoma (HP:0002859) | 1.82231030 |
| 165 | Cafe-au-lait spot (HP:0000957) | 1.82112870 |
| 166 | Low anterior hairline (HP:0000294) | 1.80969599 |
| 167 | Upper motor neuron abnormality (HP:0002127) | 1.78966633 |
| 168 | Anhidrosis (HP:0000970) | 1.78120153 |
| 169 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.77893998 |
| 170 | Menstrual irregularities (HP:0000858) | 1.77626689 |
| 171 | Recurrent viral infections (HP:0004429) | 1.77035844 |
| 172 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.75235763 |
| 173 | Aplasia cutis congenita (HP:0001057) | 1.75168676 |
| 174 | Myelodysplasia (HP:0002863) | 1.74774133 |
| 175 | Increased nuchal translucency (HP:0010880) | 1.74700931 |
| 176 | Cubitus valgus (HP:0002967) | 1.74403967 |
| 177 | Sandal gap (HP:0001852) | 1.73882136 |
| 178 | Biliary tract neoplasm (HP:0100574) | 1.73701677 |
| 179 | Inappropriate behavior (HP:0000719) | 1.73470205 |
| 180 | Neoplasm of the small intestine (HP:0100833) | 1.72560804 |
| 181 | Abnormality of macrophages (HP:0004311) | 1.72223944 |
| 182 | Thickened calvaria (HP:0002684) | 1.69141792 |
| 183 | Conjunctival telangiectasia (HP:0000524) | 1.68875684 |
| 184 | Abnormality of the pons (HP:0007361) | 1.68373096 |
| 185 | Abnormality of the gastric mucosa (HP:0004295) | 1.68060326 |
| 186 | Long clavicles (HP:0000890) | 1.67739070 |
| 187 | Insomnia (HP:0100785) | 1.67684364 |
| 188 | Deviation of the thumb (HP:0009603) | 1.67374833 |
| 189 | Submucous cleft hard palate (HP:0000176) | 1.66919952 |
| 190 | Abnormality of the preputium (HP:0100587) | 1.66185042 |
| 191 | Cutaneous melanoma (HP:0012056) | 1.66163964 |
| 192 | Ragged-red muscle fibers (HP:0003200) | 1.65391555 |
| 193 | Increased density of long bones (HP:0006392) | 1.65290699 |
| 194 | Uterine neoplasm (HP:0010784) | 1.64981215 |
| 195 | Osteomyelitis (HP:0002754) | 1.64875519 |
| 196 | Abnormality of T cell number (HP:0011839) | 1.64486043 |
| 197 | Cystic hygroma (HP:0000476) | 1.63253213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 5.36951607 |
| 2 | BCKDK | 3.90864394 |
| 3 | EIF2AK3 | 3.33263306 |
| 4 | FGFR4 | 3.29773486 |
| 5 | SCYL2 | 3.03325090 |
| 6 | MST4 | 2.96919381 |
| 7 | SIK1 | 2.86567344 |
| 8 | FRK | 2.73228782 |
| 9 | INSRR | 2.57718271 |
| 10 | ERBB4 | 2.43582020 |
| 11 | ERN1 | 2.23188455 |
| 12 | NEK1 | 2.09468680 |
| 13 | TTK | 2.08234048 |
| 14 | PRPF4B | 2.00282791 |
| 15 | EIF2AK1 | 1.99847420 |
| 16 | BUB1 | 1.88480897 |
| 17 | TYK2 | 1.86512987 |
| 18 | PTK6 | 1.73981989 |
| 19 | TNIK | 1.73689813 |
| 20 | FLT3 | 1.67021934 |
| 21 | YES1 | 1.66645063 |
| 22 | OXSR1 | 1.64294036 |
| 23 | MAP3K3 | 1.63365510 |
| 24 | ITK | 1.63077776 |
| 25 | JAK1 | 1.62538657 |
| 26 | MST1R | 1.62471199 |
| 27 | MAP2K3 | 1.61058518 |
| 28 | SRPK1 | 1.59358014 |
| 29 | MAP3K2 | 1.58549400 |
| 30 | CDC7 | 1.50706864 |
| 31 | LATS1 | 1.49556251 |
| 32 | TBK1 | 1.48518092 |
| 33 | FGFR2 | 1.45924226 |
| 34 | * MAP3K14 | 1.42975622 |
| 35 | TSSK6 | 1.40989870 |
| 36 | BRSK2 | 1.36347051 |
| 37 | IRAK3 | 1.32045347 |
| 38 | PKN2 | 1.31769480 |
| 39 | MAPK15 | 1.28909583 |
| 40 | MET | 1.24243811 |
| 41 | ACVR1B | 1.24152281 |
| 42 | PBK | 1.23766255 |
| 43 | ERBB3 | 1.23495285 |
| 44 | BMPR2 | 1.21041244 |
| 45 | IKBKE | 1.21031472 |
| 46 | BRD4 | 1.20330455 |
| 47 | TAOK1 | 1.19305164 |
| 48 | SGK3 | 1.18269683 |
| 49 | PRKAA2 | 1.17527345 |
| 50 | MAP3K7 | 1.17208956 |
| 51 | STK38L | 1.16258019 |
| 52 | FGFR3 | 1.16185992 |
| 53 | JAK2 | 1.14240829 |
| 54 | MAPK11 | 1.12984682 |
| 55 | CSK | 1.11512154 |
| 56 | NLK | 1.10736611 |
| 57 | STK10 | 1.10141043 |
| 58 | MAP3K6 | 1.09473599 |
| 59 | RIPK1 | 1.08076518 |
| 60 | WNK3 | 1.07127945 |
| 61 | PIK3CG | 1.06371654 |
| 62 | KSR1 | 1.06214853 |
| 63 | MKNK2 | 1.04430006 |
| 64 | SGK2 | 1.02439572 |
| 65 | ABL2 | 1.00913743 |
| 66 | GRK6 | 1.00509248 |
| 67 | TRIB3 | 1.00117602 |
| 68 | MAP3K12 | 0.99934344 |
| 69 | EPHB1 | 0.98715687 |
| 70 | JAK3 | 0.98594969 |
| 71 | DYRK1B | 0.98583882 |
| 72 | STK39 | 0.98569812 |
| 73 | SGK223 | 0.96715036 |
| 74 | SGK494 | 0.96715036 |
| 75 | KSR2 | 0.96328917 |
| 76 | BMPR1B | 0.95359266 |
| 77 | STK24 | 0.93617260 |
| 78 | CDK6 | 0.91964111 |
| 79 | PDGFRA | 0.91223523 |
| 80 | PLK1 | 0.90156924 |
| 81 | BLK | 0.90026256 |
| 82 | NUAK1 | 0.89276059 |
| 83 | TEC | 0.88736060 |
| 84 | PLK3 | 0.88291991 |
| 85 | CHEK2 | 0.87471619 |
| 86 | EEF2K | 0.87178929 |
| 87 | CHEK1 | 0.83582635 |
| 88 | RPS6KA4 | 0.82955784 |
| 89 | CCNB1 | 0.82432769 |
| 90 | ALK | 0.82292002 |
| 91 | EPHA3 | 0.82052255 |
| 92 | RAF1 | 0.81864869 |
| 93 | PDK2 | 0.81560781 |
| 94 | TTN | 0.80745138 |
| 95 | CHUK | 0.79714491 |
| 96 | MAP3K8 | 0.79099477 |
| 97 | PTK2 | 0.78891607 |
| 98 | IRAK2 | 0.78673782 |
| 99 | IRAK1 | 0.78128650 |
| 100 | WNK4 | 0.78086073 |
| 101 | GSK3A | 0.77981148 |
| 102 | RPS6KB2 | 0.77432760 |
| 103 | NEK9 | 0.77202297 |
| 104 | TRPM7 | 0.75779929 |
| 105 | DYRK3 | 0.74877178 |
| 106 | PDGFRB | 0.73552542 |
| 107 | PKN1 | 0.72937336 |
| 108 | LATS2 | 0.72022672 |
| 109 | STK3 | 0.71951228 |
| 110 | ICK | 0.71814567 |
| 111 | MAPK7 | 0.71804762 |
| 112 | AKT3 | 0.71314918 |
| 113 | * PRKCQ | 0.70910084 |
| 114 | CSF1R | 0.70658804 |
| 115 | SMG1 | 0.70563696 |
| 116 | FGR | 0.69112573 |
| 117 | MKNK1 | 0.68279907 |
| 118 | IKBKB | 0.67587789 |
| 119 | MAP3K5 | 0.67430530 |
| 120 | ERBB2 | 0.66193641 |
| 121 | MAP3K1 | 0.66100526 |
| 122 | ABL1 | 0.65698848 |
| 123 | NEK6 | 0.65600427 |
| 124 | PLK4 | 0.65593452 |
| 125 | CAMK1D | 0.64651449 |
| 126 | IRAK4 | 0.64611355 |
| 127 | WEE1 | 0.64471670 |
| 128 | IGF1R | 0.63912339 |
| 129 | PAK4 | 0.63808523 |
| 130 | MELK | 0.62896014 |
| 131 | TIE1 | 0.62844539 |
| 132 | MAP2K4 | 0.61604309 |
| 133 | MAP4K1 | 0.61539815 |
| 134 | NEK2 | 0.61156107 |
| 135 | WNK1 | 0.60932122 |
| 136 | ATM | 0.60551091 |
| 137 | CAMK1G | 0.60526582 |
| 138 | BTK | 0.58747921 |
| 139 | MAP3K10 | 0.58680161 |
| 140 | CSNK1A1L | 0.58490045 |
| 141 | PASK | 0.55680554 |
| 142 | CSNK1G1 | 0.55290318 |
| 143 | CDK7 | 0.54690202 |
| 144 | EPHA2 | 0.54495395 |
| 145 | CDK9 | 0.54210339 |
| 146 | BRAF | 0.53993576 |
| 147 | PIM1 | 0.52939624 |
| 148 | EGFR | 0.52031527 |
| 149 | MAPK12 | 0.51440509 |
| 150 | TAF1 | 0.51281782 |
| 151 | PRKAA1 | 0.50580657 |
| 152 | ATR | 0.49531195 |
| 153 | CLK1 | 0.49205092 |
| 154 | CDK12 | 0.49188179 |
| 155 | STK16 | 0.49101482 |
| 156 | MTOR | 0.48889169 |
| 157 | MAP3K13 | 0.48711911 |
| 158 | STK4 | 0.47603822 |
| 159 | TGFBR2 | 0.46568777 |
| 160 | MAPK4 | 0.44136717 |
| 161 | ZAK | 0.44124160 |
| 162 | BMX | 0.43209639 |
| 163 | CDK4 | 0.43159000 |
| 164 | TXK | 0.42500595 |
| 165 | EIF2AK2 | 0.41904482 |
| 166 | INSR | 0.40850566 |
| 167 | PIK3CA | 0.40237692 |
| 168 | PDPK1 | 0.40221547 |
| 169 | FGFR1 | 0.39761167 |
| 170 | SGK1 | 0.39252954 |
| 171 | EPHB2 | 0.37705205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.29416237 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.46683813 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.25051014 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.80631134 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.74177550 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.71337711 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.64762147 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.50377014 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.49236730 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.46242125 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.40985512 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.38755673 |
| 13 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.32976400 |
| 14 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.31726133 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.29593569 |
| 16 | Cell cycle_Homo sapiens_hsa04110 | 2.18882940 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.17756538 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.15987929 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14280482 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 2.03620264 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.01908071 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.91768648 |
| 23 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.89602456 |
| 24 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.89242802 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.86971090 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86844514 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.86326097 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85749494 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78688330 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.78077333 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.75515457 |
| 32 | * Pancreatic cancer_Homo sapiens_hsa05212 | 1.71478113 |
| 33 | DNA replication_Homo sapiens_hsa03030 | 1.71283746 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70228056 |
| 35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.69575705 |
| 36 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.68817719 |
| 37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.67343860 |
| 38 | Thyroid cancer_Homo sapiens_hsa05216 | 1.65294124 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.63306823 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.58358089 |
| 41 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.54978789 |
| 42 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.52738065 |
| 43 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.50394557 |
| 44 | RNA transport_Homo sapiens_hsa03013 | 1.47230032 |
| 45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.46580131 |
| 46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.43656771 |
| 47 | Mismatch repair_Homo sapiens_hsa03430 | 1.42855721 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.42090255 |
| 49 | * Measles_Homo sapiens_hsa05162 | 1.41154324 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.39064693 |
| 51 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.38595545 |
| 52 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.37866713 |
| 53 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.37154276 |
| 54 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.36104680 |
| 55 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.33460348 |
| 56 | * Hepatitis B_Homo sapiens_hsa05161 | 1.33294842 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.28752535 |
| 58 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 1.28397085 |
| 59 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.27733506 |
| 60 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.26010802 |
| 61 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.22995048 |
| 62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.22042532 |
| 63 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19600925 |
| 64 | Bladder cancer_Homo sapiens_hsa05219 | 1.19404256 |
| 65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.19133836 |
| 66 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.18925711 |
| 67 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.18828287 |
| 68 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.18153219 |
| 69 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.17460801 |
| 70 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.16794413 |
| 71 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.16612368 |
| 72 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.16102120 |
| 73 | Influenza A_Homo sapiens_hsa05164 | 1.14947929 |
| 74 | Colorectal cancer_Homo sapiens_hsa05210 | 1.13813920 |
| 75 | Endometrial cancer_Homo sapiens_hsa05213 | 1.13644597 |
| 76 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.12618135 |
| 77 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.11695073 |
| 78 | Spliceosome_Homo sapiens_hsa03040 | 1.11198483 |
| 79 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.09810122 |
| 80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.09543715 |
| 81 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.08093218 |
| 82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.08060100 |
| 83 | Lysine degradation_Homo sapiens_hsa00310 | 1.05195400 |
| 84 | * Small cell lung cancer_Homo sapiens_hsa05222 | 1.04504921 |
| 85 | * Apoptosis_Homo sapiens_hsa04210 | 1.04117274 |
| 86 | * Shigellosis_Homo sapiens_hsa05131 | 1.03530138 |
| 87 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.03113294 |
| 88 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.02827708 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | 1.02201010 |
| 90 | * Prostate cancer_Homo sapiens_hsa05215 | 1.01779752 |
| 91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01229763 |
| 92 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.98425903 |
| 93 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.96826059 |
| 94 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.94577972 |
| 95 | Adherens junction_Homo sapiens_hsa04520 | 0.94185492 |
| 96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93904507 |
| 97 | Tuberculosis_Homo sapiens_hsa05152 | 0.93734611 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93054962 |
| 99 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.90797391 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.90532203 |
| 101 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.90202880 |
| 102 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.89200962 |
| 103 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88783509 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.88750119 |
| 105 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.88509769 |
| 106 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.88227827 |
| 107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.88113676 |
| 108 | Leishmaniasis_Homo sapiens_hsa05140 | 0.87952541 |
| 109 | Salmonella infection_Homo sapiens_hsa05132 | 0.87568502 |
| 110 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.85522104 |
| 111 | Carbon metabolism_Homo sapiens_hsa01200 | 0.84694606 |
| 112 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.84371789 |
| 113 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.83307067 |
| 114 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83113064 |
| 115 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.82481846 |
| 116 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.82016224 |
| 117 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.78352508 |
| 118 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78264784 |
| 119 | Glioma_Homo sapiens_hsa05214 | 0.77852093 |
| 120 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.77757838 |
| 121 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.76154714 |
| 122 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75324194 |
| 123 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.74155180 |
| 124 | Basal transcription factors_Homo sapiens_hsa03022 | 0.71740208 |
| 125 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71534777 |
| 126 | RNA degradation_Homo sapiens_hsa03018 | 0.71309426 |
| 127 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.70668204 |
| 128 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70612765 |
| 129 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68973599 |
| 130 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.68378556 |
| 131 | Sulfur relay system_Homo sapiens_hsa04122 | 0.67903853 |
| 132 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67515668 |
| 133 | * Toxoplasmosis_Homo sapiens_hsa05145 | 0.67022019 |
| 134 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66883061 |
| 135 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.66418323 |
| 136 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.66358226 |
| 137 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.64420355 |
| 138 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.63230790 |
| 139 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.60733722 |
| 140 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.60276344 |
| 141 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.59125942 |
| 142 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56388531 |
| 143 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55364727 |
| 144 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.44372475 |
| 145 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43261418 |
| 146 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38595670 |
| 147 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.38526798 |
| 148 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32450784 |
| 149 | Insulin resistance_Homo sapiens_hsa04931 | 0.28751668 |
| 150 | Prion diseases_Homo sapiens_hsa05020 | 0.27179049 |
| 151 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21661532 |
| 152 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20739291 |
| 153 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.16244581 |
| 154 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13918556 |
| 155 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.12588738 |
| 156 | Galactose metabolism_Homo sapiens_hsa00052 | 0.10347622 |
| 157 | Mineral absorption_Homo sapiens_hsa04978 | 0.10035203 |
| 158 | * Hepatitis C_Homo sapiens_hsa05160 | 0.04702432 |
| 159 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.03145255 |
| 160 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.03048425 |
| 161 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.02731474 |
| 162 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.01779203 |
| 163 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -3.1869180 |
| 164 | Amoebiasis_Homo sapiens_hsa05146 | -0.0914600 |
| 165 | * TNF signaling pathway_Homo sapiens_hsa04668 | -0.0875745 |
| 166 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0815370 |
| 167 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.0782735 |
| 168 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0766196 |
| 169 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0718284 |
| 170 | Malaria_Homo sapiens_hsa05144 | -0.0618921 |
| 171 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0538787 |
| 172 | Lysosome_Homo sapiens_hsa04142 | -0.0522624 |
| 173 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0449515 |
| 174 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0448220 |
| 175 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0271080 |
| 176 | Legionellosis_Homo sapiens_hsa05134 | -0.0187747 |
| 177 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0108524 |
| 178 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0067979 |
| 179 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0043976 |
| 180 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | -0.0037971 |

